Recently, transcription factors Sp1, Sp3 and Egr-1 have been identified as potent regulators of MT1-MMP expression in prostate cancer, endothelial and glomerular mesangial cells [24,32,33]. This evidence concerns the gene SP3 and prostate cancer.